Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $285.11 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $100.00 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $93.40 | 6 | $0 (2024) |
| BeiGene USA, Inc. | $49.02 | 1 | $0 (2024) |
| Daiichi Sankyo Inc. | $17.50 | 1 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.28 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $11.91 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $84.00 | 3 | BeiGene USA, Inc. ($49.02) |
| 2023 | $44.31 | 3 | AstraZeneca Pharmaceuticals LP ($31.03) |
| 2019 | $14.32 | 1 | AstraZeneca Pharmaceuticals LP ($14.32) |
| 2018 | $13.07 | 1 | AstraZeneca Pharmaceuticals LP ($13.07) |
| 2017 | $129.41 | 3 | GENZYME CORPORATION ($100.00) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/26/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $49.02 | General |
| Category: Oncology | ||||||
| 02/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Respiratory | ||||||
| 09/11/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/14/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: DIABETES | ||||||
| 01/30/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/13/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/06/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/21/2017 | Daiichi Sankyo Inc. | Movantik (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Opioid Induced Constipation | ||||||
| 07/27/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/10/2017 | GENZYME CORPORATION | DISEASE STATE (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 6 | 176 | 206 | $31,070 | $16,767 |
| 2021 | 8 | 278 | 417 | $58,110 | $31,011 |
| 2020 | 7 | 305 | 516 | $69,065 | $35,126 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 32 | 34 | $7,310 | $4,272 | 58.4% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 46 | 50 | $8,250 | $4,134 | 50.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 23 | 25 | $4,000 | $2,361 | 59.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 21 | 41 | $3,690 | $2,130 | 57.7% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 37 | 38 | $4,940 | $2,058 | 41.7% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 17 | 18 | $2,880 | $1,813 | 62.9% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 73 | 147 | $19,110 | $7,886 | 41.3% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 47 | 54 | $11,610 | $7,344 | 63.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 53 | 65 | $10,400 | $6,428 | 61.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 36 | 80 | $7,200 | $4,328 | 60.1% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 23 | 23 | $3,795 | $2,013 | 53.0% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 12 | 13 | $2,080 | $1,330 | 63.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 11 | 12 | $1,500 | $965.64 | 64.4% |
| 99282 | Emergency department visit, low to moderately severe problem | Facility | 2021 | 23 | 23 | $2,415 | $716.13 | 29.7% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 83 | 192 | $24,960 | $9,040 | 36.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 44 | 129 | $11,610 | $7,224 | 62.2% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 47 | 49 | $10,535 | $6,327 | 60.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 45 | 54 | $8,640 | $5,594 | 64.7% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 35 | 39 | $6,435 | $3,520 | 54.7% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2020 | 24 | 24 | $3,840 | $2,510 | 65.4% |
| 99282 | Emergency department visit, low to moderately severe problem | Facility | 2020 | 27 | 29 | $3,045 | $911.22 | 29.9% |
About Dr. Naim Rahman, M.D
Dr. Naim Rahman, M.D is a Internal Medicine healthcare provider based in Macon, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679507024.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Naim Rahman, M.D has received a total of $285.11 in payments from pharmaceutical and medical device companies, with $84.00 received in 2024. These payments were reported across 11 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($285.11).
As a Medicare-enrolled provider, Rahman has provided services to 759 Medicare beneficiaries, totaling 1,139 services with total Medicare billing of $82,904. Data is available for 3 years (2020–2022), covering 21 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Macon, MS
- Active Since 07/10/2006
- Last Updated 02/27/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1679507024
Products in Payments
- DISEASE STATE (Drug) $100.00
- FARXIGA (Drug) $76.28
- BRUKINSA (Drug) $49.02
- Movantik (Drug) $17.50
- BREZTRI (Drug) $17.12
- JARDIANCE (Drug) $13.28
- ENTRESTO (Drug) $11.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Macon
Sagar Panse, M.d, M.D
Internal Medicine — Payments: $784,712
Quyen Luu, Md, MD
Internal Medicine — Payments: $54,100
Lesley Cown, M.d., L.l.c, M.D., L.L.C
Internal Medicine — Payments: $39,643
Jonathan Brock, M.d, M.D
Internal Medicine — Payments: $31,696
Dr. Ahmad Kabbani, Md, MD
Internal Medicine — Payments: $15,693
Dr. Alan Justice, M.d, M.D
Internal Medicine — Payments: $14,983